FloQast Secures $100 Million in Series E Funding, Achieving $1.6 Billion Valuation
Globe Newswire10-04-2024, 20:00
Zymeworks Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating ZW191 in Folate Receptor-⍺ Expressing Advanced Solid Tumors 5-11-2024, 18:00